In this video interview, Cheryl Kole, vice president of solution strategy and commercialization at Almac Clinical ...
In today's ACT Brief, we explore how user-friendly technology reduces errors and site workarounds, strategic approaches to ...
As the clinical research landscape evolves, decentralized clinical trials (DCTs) have emerged as a foundational competency, ...
In part 2 of this three-part series, behavioral science and service design reveal how poor experiences with confusing ...
Discover how Quest Diagnostics’ comprehensive lab data can elevate your clinical trials. Our latest white paper, "6 Ways Lab ...
Vaccine developers can reduce participant burden and extend follow-up timelines by strategically combining traditional site visits with real-world data collection, but the choice depends on follow-up ...
Vaccine developers can reduce participant burden and extend follow-up timelines by strategically combining traditional site visits with real-world data collection, but the choice depends on follow-up ...
Long-term follow-up is a necessity for vaccine development, and is critical for establishing safety data, determining how ...
Kole identified workflow guidance as the most underaddressed gap in current eClinical ecosystems, arguing that technology has ...
Identify how AI tools can alleviate the workload of small discovery teams by automating preclinical documentation, reducing ...
In today's ACT Brief, we examine the three converging technology priorities reshaping trial execution in 2026, why sponsors ...
As clinical trials grow more complex, the technology infrastructure supporting them is under renewed scrutiny. Across data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results